Find out what’s new and what’s next in treatment options for ATTR-CM.
-
-
Benefits of gene-silencing therapies in ATTR-CM may depend on TTR stabilizer use
-
Educate, motivate, advocate: The media’s potential in the rare disease space
-
Clinical trial to examine if acoramidis can reverse heart changes in ATTR-CM
-
ATTR-CM looks different in women and men
-
SGLT2i use reduces hospitalizations and mortality in ATTR-CM
-
Eplontersen falls short in major ATTR-CM study